1- Biodiversity Research Centre, Dhofar University
2- Biodiversity Research Center, Dhofar University
3- Biodiversity Research Center, Dhofar University , lrashan@du.edu.om
Abstract: (32 Views)
Abstract
Introduction: Antimicrobial resistance (AMR) is currently one of the most serious threats to human health worldwide. The rapid spread and emergence of multidrug-resistant (MDR) pathogens, including methicillin-, vancomycin-, extended-spectrum β-lactam-, colistin-, and carbapenem-resistant organisms, have made microbial infections difficult to treat. Existing antimicrobials have been widely misused and are becoming largely ineffective, with some also associated with serious side effects. Developing effective, new, and safe antimicrobials is one strategy to reduce the burden of AMR. There is a growing interest in exploring medicinal plants as a source of antimicrobial therapies. Oman has a rich heritage of medicinal plants, and several studies have evaluated their antibacterial activities.
Methods: We reviewed published studies on the antibacterial activity of Omani medicinal plants by searching the PubMed, Google Scholar, Web of Science, and Scopus databases from 2000 to 2006. The studies were systematically compiled to assess the available evidence regarding the antimicrobial properties of these plants.
Results: Studies have reported antibacterial activity of several Omani medicinal plants using preliminary antimicrobial assays, including disc diffusion and liquid dilution assays. None of these studies has provided insight into the antimicrobial mechanism of action of these plants. The compilation of these studies provides an overview of the antimicrobial potential of Omani medicinal plants and their possible role as sources of new antimicrobial agents.
Conclusion: The purpose of this study is to provide insight into the antimicrobial activity of Omani medicinal plants. The findings may help identify plant species with antibacterial activity that warrant further investigation and characterization as potential sources of antibacterial compounds. However, the observed in vitro activity does not establish clinical efficacy, safety, or therapeutic potential, and further in vivo and clinical studies are required to determine their relevance to addressing AMR.

Type of Study:
Review/Systemtic review |
Subject:
Bioactive Compounds Received: 2026/09/13 | Accepted: 2026/11/1 | Published: 2026/09/6